ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

TUSSICAPS 5mg/4mg
Cough and cold
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

TUSSICAPS 5mg/4mg CII

Generic Name and Formulations:
Hydrocodone bitartrate 5mg, chlorpheniramine maleate 4mg; as polistirex; ext-rel caps; contains alcohol.

Company:
Mallinckrodt, Inc.

Therapeutic Use:

Indications for TUSSICAPS 5mg/4mg:

Cough and upper respiratory symptoms.

Adult:

1 cap (10mg/8mg) every 12hrs; max 2caps/24hrs.

Children:

<6yrs: see Contraindications. 6–11yrs: 1 cap (5mg/4mg) every 12hrs; max 2caps/24hrs.

Contraindications:

Children <6yrs of age (risk of fatal respiratory depression).

Warnings/Precautions:

Respiratory depression. Post–op. Pulmonary disease. Head injury. Increased intracranial pressure. Glaucoma. Asthma. GI or GU obstruction. Acute abdomen. Severe hepatic or renal impairment. Hypothyroidism. Addison's disease. Elderly. Debilitated. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended.

See Also:

TUSSICAPS 10mg/8mg

Pharmacological Class:

Antitussive + antihistamine.

Interactions:

Additive CNS depression with alcohol, other CNS depressants, tricyclic antidepressants, MAOIs. Paralytic ileus with concurrent anticholinergics.

Adverse Reactions:

Nausea, vomiting, CNS and respiratory depression, ureteral and vesical sphincter spasm, chest tightness, abuse potential, anticholinergic effects, rash, pruritis.

How Supplied:

Caps—20, 100


Data provided by MPR.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs